Generating evidence on the use, effectiveness, and safety of new cancer therapies is a
priority for researchers, health care providers, payers, and regulators given the rapid pace of …

… Donna R Rivera , Donna R Rivera … Lindsey Enewold, Helen Parsons, Lirong Zhao, David
Bott, Donna R Rivera, Michael J Barrett, Beth A Virnig, Joan L Warren, Updated Overview of the …

Background Data on patients with COVID-19 who have cancer are lacking. Here we characterise
the outcomes of a cohort of patients with cancer and COVID-19 and identify potential …

Breast cancer is the most common cancer among women worldwide, and survival rates are
increasing. Chemotherapy-associated peripheral neuropathy (PN) is clinically important …

Importance The emergency department (ED) is used to manage cancer-related complications
among the 15.5 million people living with cancer in the United States. However, ED …

The purpose of this study was to evaluate the potential collective opportunities and challenges
of transforming real‐world data (RWD) to real‐world evidence for clinical effectiveness by …

Evaluating the potential role of COVID-19 treatments in patients with cancer in a large
observational study, there was no statistically significant 30-day all-cause mortality benefit with …

Many children who require augmentative and alternative communication (AAC) have difficulties
shifting from the single- to multi-symbol stage of language development. Ensuring that …

Rapid advancements in cancer discovery, diagnosis, and treatment options available to
patients with cancer have highlighted the need for enhancements in clinical trial design. The …

Purpose There are no nationally representative data on oncologists’ use of next-generation
sequencing (NGS) testing in practice. The purpose of this study was to investigate how …